Nervous System Diseases

1,005 trials 421 recruiting

Filter these 1,005 trials by phase, country and sponsor.

Open in Search →

TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A Prospective, randomised-controlled, double-dummy, double-blind phase 3 … Recruiting

2024-517606-29-00 Central retinal artery occlusion 5 2020-10-30
Safety and Tolerability of Cariprazine in the Treatment of Adolescent Patients with Schizophrenia Recruiting

2024-513222-30-00 Adolescent patient (13-17 years of age) with Schizophre 5 2020-02-20
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generali… Recruiting

2023-506688-32-00 Primary Generalized Tonic-Clonic Seizures 5 2019-10-09
Randomized, double-blind, placebo-controlled, multicenter Phase 2 trial assessing the effect of IMU-838 on disease activity, as measured by … Recruiting

2024-516739-29-00 Relapsing-remitting multiple sclerosis 4 2019-01-23
Exploratory study on the effect of Rimonabant on hand function in patients with spinal cord injury (RIMOHANDOPEN) Recruiting

2025-524279-22-00 Spinal cord injury 9 2026-05-22
DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL Recruiting

2025-522687-33-00 Stroke 5 2026-05-19
A clinical trial of MK-4605 in healthy participants (MK-4605-001) Recruiting

2026-525627-24-00 Dementia 1 2026-05-13
Cerebral hemodynamic optimization by milrinone for the prevention of delayed cerebral ischemia in severe subarachnoid hemorrhage Recruiting

2024-513410-35-00 aneurysmal subarachnoid hemorrhage 5 2026-05-12
Effect of NBI-921355 on corticospinal excitability in healthy participants Recruiting

2025-524134-26-00 Epilepsy 3 2026-05-08
A Phase 2, Multicenter, Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Ublituximab Administered at Various Injection Site… Recruiting

2025-523757-33-00 multiple sclerosis 4 2026-05-07
Allogeneic adipose tissue derived-stem cells in Alzheimer disease Recruiting

2022-502846-28-00 Alzheimer 3 2026-05-07
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults Recruiting

2025-525125-12-00 Migraine with or without aura 2 2026-05-05
A PET-MRI study of serotoninergic brainstem pathway in patients with Dravet Syndrome - DRAPETONINE Recruiting

2025-524199-40-00 neurology 4 2026-05-04
Insulin nasal spray to prevent delirium after cardiac surgery Recruiting

2025-524680-21-00 Delirium 10 2026-04-29
The clinical trial to study a new drug, AP-2. Recruiting

2025-524480-21-00 ALS and related disorders like frontotemporal dementia 1 2026-04-24
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Secondary progressive multiple sclerosis 5 2026-04-21
Efficacy of early continuous infusion of hypertonic saline solution on the neurological outcome at 6 months in traumatic brain injured patie… Recruiting

2024-520205-39-00 Traumatic brain injury 5 2026-04-21
Non-inferiority study of frexalimab subcutaneous administration compared to intravenous administration in adult participants with multiple s… Recruiting

2024-519304-28-00 Multiple Sclerosis 5 2026-04-20
Evaluating oral peri-operative acetylsalicylic acid in subjects undergoing endovascular coiling-only of unruptured brain aneurysms Recruiting

2024-517674-23-00 Subjects undergoing elective endovascular coiling-only 5 2026-04-09
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Dose Comparison and Exploratory Efficacy Study of Orally Administered SAT-3247 in A… Recruiting

2025-522522-13-01 Duchenne muscular dystrophy 4 2026-04-08
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants with Early Alzheimer’s Diseas… Recruiting

2025-523515-11-00 Early Alzheimer's Disease 1 2026-04-03
A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women Recruiting

2026-525208-90-00 Multiple sclerosis 3 2026-04-01
MB-CART2019.1 in refractory MS Recruiting

2024-517601-82-00 refractory Multiple Sclerosis 9 2026-04-01
Is [18F]-DPA-714 PET a good marker of neuroinflammation in autoimmune encephalitis? (EAI-714) Recruiting

2025-522768-33-00 autoimmune encephalitis 4 2026-03-31